Need to keep on high of the science and politics driving biotech at present? Join to get our biotech e-newsletter in your inbox.
At the moment, we discover how an formidable nonprofit is taking management of a shelved gene remedy, because it seeks to create a brand new mannequin for commercializing therapies not deemed profitable by pharma. Additionally, we see international scientific fear over inside NIH emails that say worldwide collaborations could be reduce off.
